Table 2. The rate of oxidative phosphorylation in SSM from young and aged mice with or without metformin treatment.
Mice | 3 mo. | 24 mo. | ||
Groups | Vehicle (n=13) | Metformin (n=5) | Vehicle (n=11) | Metformin (n=5) |
Complex I substrates: glutamate + malate | ||||
State 3 (nAO/min/mg) | 291±16 | 326±7 | 220±14* | 243±13 |
State 4 (nAO/min/mg) | 44±4 | 48±3 | 37±2 | 41±2 |
RCR | 6.9±0.4 | 7.1±0.5 | 6.1±0.3 | 6.1±0.6 |
2 mM ADP (nAO/min/mg) | 345±16 | 377±6 | 251±21* | 272±25 |
Complex II substrates: Succinate + rotenone | ||||
State 3 (nAO/min/mg) | 642±25 | 587±24 | 557±20* | 599±30 |
State 4 (nAO/min/mg) | 179±8 | 172±8 | 149±5* | 156±6 |
RCR | 3.6±0.1 | 3.4±0.1 | 3.7±0.1 | 3.9±0.2 |
2 mM ADP (nAO/min/mg) | 593±25 | 529±22 | 532±21 | 545±23 |
Mean ± SEM. *p<0.05 vs. 3 mo. Vehicle.